 |
Pharmos Announces Dosing of First Patients in Clinical Trial of Levotofisopam for the Treatment of Gout
ISELIN, N.J., Jan. 10, 2012 /PRNewswire/ -- Pharmos Corporation (OTC-PINK: PARS) announced today the dosing of the first patients in the US using its compound levotofisopam (S-tofisopam) to treat patients with hyperuricemia and gout.
Omega Protein to Present at the 14th Annual ICR XChange Conference
HOUSTON, Jan. 3, 2012 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional ingredient company and the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today announced that Bret Scholtes, the Company's President & Chief Executive Officer, and Andrew Johannesen, Executive Vice President & Chief Financial Officer, will present at the ICR XChange Conference on Thursday, January 12, 2012 at 9:50 a.m.
Omega Protein Completes Executive Management Succession Plan
HOUSTON, Jan. 3, 2012 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional ingredient company and the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today announced the completion of its previously announced executive management succession plan.
Joseph L.
|
Home
Site Map
buy this site
Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat
HAYWARD, Calif., Dec. 8, 2011 /PRNewswire/ -- Metabolex today announced positive results from its clinical study of arhalofenate in combination with febuxostat (Uloricâ„¢, Takeda Pharmaceutical Company Limited).
Omega Protein to Present at the 14th Annual ICR XChange Conference
HOUSTON, Jan. 3, 2012 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional ingredient company and the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today announced that Bret Scholtes, the Company's President & Chief Executive Officer, and Andrew Johannesen, Executive Vice President & Chief Financial Officer, will present at the ICR XChange Conference on Thursday, January 12, 2012 at 9:50 a.m.
Omega-3 Fatty Acids Associated with Improved Markers of Heart Disease and More
DENVER, Dec. 15, 2011 /PRNewswire-USNewswire/ -- Omega-3 polyunsaturated fatty acids (PUFAs) found in seafood are associated with lower risk of heart disease, improved immune function, health advantages in preterm infants and possibly lower risk of suicide, according to new research.
Omega-3 Power Boosts Health
There's something fishy going on. Omega-3 fatty acids, once found primarily in fatty fish, are being added to all sorts of foods, including fruit juices, soy milk, eggs, nutrition bars, cereal, yogurt -- even infant formula. In fact, they've become the wonder nutrient du jour, largely because researchers are discovering more and more health benefits associated with them. "Since omega-3 fatty acids have a positive effect on the fragile membrane systems of all the cells throughout the body, they can benefit numerous organ systems," explains Barry Swanson, Ph.D., fellow of the Institute of Food Technologists and professor of food science at Washington State University in Pullman.
U.S. Market for Nutritional Solutions in Cognitive Health
NEW YORK, Nov. 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
U.S. Market for Nutritional Solutions in Cognitive Health
This research service tracks the key trends in the U.S.
|
